381 related articles for article (PubMed ID: 33442449)
1. Pivotal role of long non-coding ribonucleic acid-X-inactive specific transcript in regulating immune checkpoint programmed death ligand 1 through a shared pathway between miR-194-5p and miR-155-5p in hepatocellular carcinoma.
Atwa SM; Handoussa H; Hosny KM; Odenthal M; El Tayebi HM
World J Hepatol; 2020 Dec; 12(12):1211-1227. PubMed ID: 33442449
[TBL] [Abstract][Full Text] [Related]
2. A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma.
Assal RA; Elemam NM; Mekky RY; Attia AA; Soliman AH; Gomaa AI; Efthimiadou EK; Braoudaki M; Fahmy SA; Youness RA
Transl Oncol; 2024 Jul; 45():101961. PubMed ID: 38631259
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs XIST and MALAT1 hijack the PD-L1 regulatory signaling pathway in breast cancer subtypes.
Samir A; Tawab RA; El Tayebi HM
Oncol Lett; 2021 Aug; 22(2):593. PubMed ID: 34149904
[TBL] [Abstract][Full Text] [Related]
4. Oleuropin controls miR-194/XIST/PD-L1 loop in triple negative breast cancer: New role of nutri-epigenetics in immune-oncology.
Hamed MM; Handoussa H; Hussein NH; Eissa RA; Abdel-Aal LK; El Tayebi HM
Life Sci; 2021 Jul; 277():119353. PubMed ID: 33798547
[TBL] [Abstract][Full Text] [Related]
5. XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p.
Lin XQ; Huang ZM; Chen X; Wu F; Wu W
Yonsei Med J; 2018 Sep; 59(7):816-826. PubMed ID: 30091314
[TBL] [Abstract][Full Text] [Related]
6. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1.
Selem NA; Nafae H; Manie T; Youness RA; Gad MZ
Pathol Res Pract; 2023 Aug; 248():154579. PubMed ID: 37301086
[TBL] [Abstract][Full Text] [Related]
7. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer.
Mekky RY; Ragab MF; Manie T; Attia AA; Youness RA
Transl Oncol; 2023 May; 31():101653. PubMed ID: 36907052
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV Attenuates Programmed Death-Ligand 1-Mediated Immunosuppression during Liver Cancer Development via the miR-135b-5p/CNDP1 Axis.
Ma Y; Li Y; Wu T; Li Y; Wang Q
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894415
[TBL] [Abstract][Full Text] [Related]
9. The EGFR-P38 MAPK axis up-regulates PD-L1 through miR-675-5p and down-regulates HLA-ABC via hexokinase-2 in hepatocellular carcinoma cells.
Liu Z; Ning F; Cai Y; Sheng H; Zheng R; Yin X; Lu Z; Su L; Chen X; Zeng C; Wang H; Liu L
Cancer Commun (Lond); 2021 Jan; 41(1):62-78. PubMed ID: 34236149
[TBL] [Abstract][Full Text] [Related]
10. LncRNA X inactive specific transcript contributes to neuropathic pain development by sponging miR-154-5p via inducing toll-like receptor 5 in CCI rat models.
Wei M; Li L; Zhang Y; Zhang ZJ; Liu HL; Bao HG
J Cell Biochem; 2019 Feb; 120(2):1271-1281. PubMed ID: 30335888
[TBL] [Abstract][Full Text] [Related]
11. XIST and TSIX: Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer Patients.
Salama EA; Adbeltawab RE; El Tayebi HM
Front Oncol; 2019; 9():1459. PubMed ID: 31998636
[TBL] [Abstract][Full Text] [Related]
12. Long Non-coding RNA XIST May Influence Cervical Ossification of the Posterior Longitudinal Ligament Through Regulation of miR-17-5P/AHNAK/BMP2 Signaling Pathway.
Liao X; Tang D; Yang H; Chen Y; Chen D; Jia L; Yang L; Chen X
Calcif Tissue Int; 2019 Dec; 105(6):670-680. PubMed ID: 31511959
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of long non-coding RNA XIST suppresses nasopharyngeal carcinoma progression by activating miR-491-5p.
Cheng Q; Xu X; Jiang H; Xu L; Li Q
J Cell Biochem; 2018 May; 119(5):3936-3944. PubMed ID: 29219216
[TBL] [Abstract][Full Text] [Related]
14. Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished
Kulkarni P; Dasgupta P; Bhat NS; Shahryari V; Shiina M; Hashimoto Y; Majid S; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
Mol Cancer Res; 2018 Nov; 16(11):1750-1760. PubMed ID: 30037856
[TBL] [Abstract][Full Text] [Related]
15. [Effect of
Yuan J; Han H; Dong W; Wang RC; Hao HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):96-103. PubMed ID: 36765483
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p.
Zhou WY; Zhang MM; Liu C; Kang Y; Wang JO; Yang XH
J Cell Physiol; 2019 Dec; 234(12):23176-23189. PubMed ID: 31206665
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA XIST contributes to osteoarthritis progression via miR-149-5p/DNMT3A axis.
Liu Y; Liu K; Tang C; Shi Z; Jing K; Zheng J
Biomed Pharmacother; 2020 Aug; 128():110349. PubMed ID: 32521454
[TBL] [Abstract][Full Text] [Related]
18. The
Xu G; Mo L; Wu C; Shen X; Dong H; Yu L; Pan P; Pan K
Ren Fail; 2019 Nov; 41(1):955-966. PubMed ID: 31658856
[No Abstract] [Full Text] [Related]
19. MicroRNA-93-5p expression in tumor tissue and its tumor suppressor function via targeting programmed death ligand-1 in colorectal cancer.
Chen YL; Wang GX; Lin BA; Huang JS
Cell Biol Int; 2020 May; 44(5):1224-1236. PubMed ID: 32068322
[TBL] [Abstract][Full Text] [Related]
20. Long Non-coding RNA XIST Attenuates Diabetic Peripheral Neuropathy by Inducing Autophagy Through MicroRNA-30d-5p/
Liu BY; Li L; Bai LW; Xu CS
Front Mol Biosci; 2021; 8():655157. PubMed ID: 33996907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
